These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15385955)

  • 21. Alternative function of a protein kinase homology domain in 2', 5'-oligoadenylate dependent RNase L.
    Dong B; Silverman RH
    Nucleic Acids Res; 1999 Jan; 27(2):439-45. PubMed ID: 9862963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
    Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
    J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural mechanism of sensing long dsRNA via a noncatalytic domain in human oligoadenylate synthetase 3.
    Donovan J; Whitney G; Rath S; Korennykh A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3949-54. PubMed ID: 25775560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-molecule activators of RNase L with broad-spectrum antiviral activity.
    Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
    Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments.
    Interlandi G; Wetzel SK; Settanni G; Plückthun A; Caflisch A
    J Mol Biol; 2008 Jan; 375(3):837-54. PubMed ID: 18048057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of RNABP, an RNA binding protein that associates with RNase L.
    Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
    J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bipartite model of 2-5A-dependent RNase L.
    Dong B; Silverman RH
    J Biol Chem; 1997 Aug; 272(35):22236-42. PubMed ID: 9268370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of Escherichia coli RNase D, an exoribonuclease involved in structured RNA processing.
    Zuo Y; Wang Y; Malhotra A
    Structure; 2005 Jul; 13(7):973-84. PubMed ID: 16004870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convergent synthesis of ribonuclease L-active 2',5'-oligoadenylate-peptide nucleic acids.
    Wang Z; Chen L; Bayly SF; Torrence PF
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1357-60. PubMed ID: 10890163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
    Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
    Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1.
    Donovan J; Dufner M; Korennykh A
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1652-7. PubMed ID: 23319625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage.
    Blaszczyk J; Tropea JE; Bubunenko M; Routzahn KM; Waugh DS; Court DL; Ji X
    Structure; 2001 Dec; 9(12):1225-36. PubMed ID: 11738048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
    Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
    J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A transcription blocker isolated from a designed repeat protein combinatorial library by in vivo functional screen.
    Tikhonova EB; Ethayathulla AS; Su Y; Hariharan P; Xie S; Guan L
    Sci Rep; 2015 Jan; 5():8070. PubMed ID: 25627011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis and origins of the human and mouse RNase L genes: mediators of interferon action.
    Zhou A; Nie H; Silverman RH
    Mamm Genome; 2000 Nov; 11(11):989-92. PubMed ID: 11063255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-5A-dependent RNase molecules dimerize during activation by 2-5A.
    Dong B; Silverman RH
    J Biol Chem; 1995 Feb; 270(8):4133-7. PubMed ID: 7876164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.